Radiation therapy remains the standard of care for many cancers, including the malignant pediatric brain tumor medulloblastoma. Radiation leads to long-term side effects, whereas radioresistance contributes to tumor recurrence. Radio-resistant medulloblastoma cells occupy the perivascular niche. They express Yes-associated protein (YAP), a Sonic hedgehog (Shh) target markedly elevated in Shh-driven medulloblastomas. Here we report that YAP accelerates tumor growth and confers radioresistance, promoting ongoing proliferation after radiation. YAP activity enables cells to enter mitosis with un-repaired DNA through driving insulin-like growth factor 2 (IGF2) expression and Akt activation, resulting in ATM/Chk2 inactivation and abrogation of cell cycle checkpoints. Our results establish a central role for YAP in counteracting radiation-based therapies and driving genomic instability, and indicate the YAP/IGF2/Akt axis as a therapeutic target in medulloblastoma.
Introduction
Medulloblastoma, a primitive neuro-ectodermal tumor, is the most common malignant solid tumor of childhood. These tumors arise in the cerebellum, a brain structure that regulates posture and coordination, and develops largely perinatally. Current medulloblastoma therapy entails surgery, radiation and chemotherapy. Over the past half century, the long-term survival rate for children with medulloblastoma has improved remarkably ranging from 40 to 70% after 5 years, yet recurrence is frequent and the overall mortality rate remains relatively high. Moreover, survivors suffer from serious long-term treatment-related sequelae. Current therapy combines surgery and chemotherapy with craniospinal irradiation. However, the long-term side effects of radiation therapy as well as the potential induction of secondary malignancies have inspired many investigators to find ways to reduce the amount of radiation used (Mueller and Chang, 2009) .
Medulloblastomas bearing evidence of Sonic hedgehog (Shh) pathway activity, approximately 30% of cases (Northcott et al., 2011) , are proposed to arise from cerebellar granule neuron precursors (CGNPs) (Eberhart, 2008) . During cerebellar development, these cells undergo a rapid expansion phase, and their proliferation depends on activation of the Shh signaling pathway (Dahmane and Ruiz i Altaba, 1999; Wallace, 1999; Wechsler-Reya and Scott, 1999) . Shh, a secreted ligand, signals by binding to the transmembrane protein Patched (Ptc), a tumor suppressor whose function is to inhibit the activity of Smoothened, a transmembrane protein resembling a G-protein-coupled receptor. In CGNPs, Shh interactions with Ptc relieve the inhibition of Smoothened and permit downstream signaling activity, resulting in the activation of Gli, N-myc and E2F1 transcription factors, and stabilization of insulin receptor substrate-1, all of which contribute to proliferation (Ruiz i Altaba, 1999; Oliver et al., 2003; Kenney et al., 2004; Parathath et al., 2008; Bhatia et al., 2011) . Loss of Ptc or activating mutations in Smoothened are found in human medulloblastomas, and can be phenocopied in mice, through mutational inactivation of Ptc or transgenic expression of activating alleles of in the cerebellum (Goodrich et al., 1997; Hatton et al., 2008) . Recent observations in mouse models have demonstrated the importance of genome surveillance, as loss of DNA damage repair mechanisms can lead to genomic instability in neural progenitor cells, resulting in medulloblastoma, and can also cooperate with Shh signaling to enhance medulloblastoma formation in mice (Pazzaglia et al., 2006; Leonard et al., 2008; Tanori et al., 2008; Frappart et al., 2009) .
Recently, we have shown that Shh induces expression and activity of Yes-associated protein (YAP), a transcriptional co-activator that is the target of the tumor-suppressive Hippo pathway, and that YAP is highly expressed in Shh-associated medulloblastomas. YAP is known to have oncogenic properties, including the ability to promote epithelial-mesenchymal transition, suppression of apoptosis, growth factor-independent proliferation and anchorage-independent growth in soft agar (Overholtzer et al., 2006) . YAP is involved in the formation of numerous tumors, including glioblastomas, oral squamous-cell carcinomas, and cancers of the pancreas, lung, ovary and cervix (Zeng and Hong, 2008; Zhao et al., 2008; Fernandez-L and Kenney, 2010) . However, the effects exerted by YAP are highly contextdependent, as it acts as a tumor suppressor in other malignancies, such as some breast cancers (Yuan et al., 2008) . Similarly, YAP activity can have pro-or antiapoptotic effects depending on the tissue and cell context (Bertini et al., 2009) .
Here, we show that YAP contributes to medulloblastoma growth and medulloblastoma cell (MBC) survival after irradiation, through driving expression and production of insulin-like growth factor 2 (IGF2) and subsequent activation of Akt. Akt activity endows tumor cells with the ability to evade the G1/S and G2/M checkpoints after irradiation, promoting their ongoing proliferation despite the presence of un-repaired DNA, thereby contributing to genomic instability. These novel findings reveal a link between oncogenic hedgehog signaling and genomic instability, and they suggest that targeting YAP-and IGF-driven signaling pathways may have therapeutic value by restoring radiosensitivity and also permitting reduction of the radiation dose required to induce medulloblastoma tumor cell death.
Results

YAP expression promotes MBC tumorigenicity
We have previously shown that YAP is highly expressed in both human and mouse medulloblastomas, the YAP locus is highly amplified in 3% of the human medulloblastomas analyzed and YAP expression is sufficient to drive proliferation of CGNPs in the absence of their obligate mitogen Shh (Fernandez-L et al., 2009) . In NeuroD2-SmoA1 mouse medulloblastomas, YAP is most highly expressed in tumor cells surrounding blood vessels, a micro-environment known as the perivascular niche (PVN). These cells are proposed to have 'tumorrepopulating' properties, and indeed, after irradiation, these YAP-expressing cells can be found proliferating, possibly contributing to the re-growth of the tumor. To determine whether YAP expression increases MBC tumorigenicity, we cultured cells from medulloblastomas arising in NeuroD2-SmoA1 mice, infected them with retroviruses carrying either YAP or green fluorescent protein (GFP), and then implanted these cells intra-cranially into postnatal day 2 non-obese diabetic/ severe combined immune deficiency pups. We then monitored the animals for symptomatic evidence of medulloblastoma (head tilt, seizures), confirmed upon being killed and dissection of the tumors. Ectopic expression of YAP enhances medulloblastoma growth, as determined by the ability of YAP-infected NeuroD2-SmoA1 cells to form tumors in the recipient mice, more effectively than GFP-infected NeuroD2-SmoA1 cells (14/17 YAP-SmoA1-injected mice vs 8/17 GFP-SmoA1injected mice). A similar trend was observed when wildtype C57BL/6 pups were used as recipients (Supplementary Figure 1 ). Moreover, YAP expression results in a significant acceleration of lethality (long-rank test, P ¼ 0.0047; Figure 1a ; P ¼ 0.0487; Supplementary  Figure 1 ), suggesting that YAP-expressing medulloblastomas are more aggressive. YAP-SmoA1 medulloblastomas have increased proliferation as determined by increased levels of cyclin D2 and phosphorylated histone H3 (P-Hist3), markers of G1/S transition and mitosis phase of the cell cycle, respectively (Figures 1b and c). YAP-SmoA1 tumors also showed reduced levels of apoptosis as determined by decreased levels of cleaved caspase 3 compared with tumors arising from GFP-infected SmoA1 cells. In keeping with our previous results, YAP is found throughout the tumor, but is most highly expressed in PVN cells. Interestingly, YAPexpressing SmoA1 medulloblastomas also bear evidence of increased angiogenesis, suggested by higher levels of vascular endothelial growth factor and the endothelial cell marker CD31 (Figures 1b and c) .
We have previously shown that YAP-expressing cells in Shh-induced mouse medulloblastomas proliferate after the animals have been treated with radiation. We next wished to determine whether YAP expression promotes survival after irradiation. To this end, we YAP expression promotes increased proliferation, survival and cell cycle checkpoints over-ride in irradiated cerebellar neural precursors CGNPs are proposed to be the cell-of-origin for medulloblastomas associated with increased Shh pathway activity (Wechsler-Reya and Scott, 1999) . Consistent with this hypothesis, treatment of CGNPs in culture with exogenous Shh causes expression of many of the same proliferation markers seen in this class of medulloblastomas, including Gli1, N-myc and YAP. We wished to determine whether we could use in vitro primary CGNP cultures to dissect mechanistically the effects of YAP on proliferation and survival after irradiation. Cells prepared from postnatal days 4 to 5 mouse cerebella are maintained in the serum-free medium; addition of Shh sustains their proliferation. We transduced Shh-treated, proliferating CGNPs with retroviruses carrying GFP or YAP, and then irradiated them (10 Gy) 24 h later. As shown in Figure 2a , ectopic YAP expression is associated with increased CGNP proliferation as determined by cyclin D2 levels, and as we have reported previously (Fernandez-L et al., 2009) . At 20 h post-irradiation, YAP-infected CGNPs had reduced levels of cleaved caspase 3 in comparison with GFP-infected CGNPs, and reduced numbers of apoptotic cells as determined by quantification of pyknotic nuclei (GFP: 62.5±0.5% vs YAP: 35.5 ± 5.5%). YAP-transduced CGNPs were significantly more proliferative, as indicated by levels of cyclin D2, and by Ki67 and P-Hist3 staining (Figures 2a and b) . Taken together, these results indicate that CGNP cultures recapitulate the in vivo effect of YAP expression on promoting survival and proliferation after irradiation. Moreover, they suggest that YAP-mediated radiation resistance may contribute to medulloblastoma recurrence by promoting increased tumor cell survival and proliferation.
Ionizing radiation causes the formation of doublestrand DNA breaks that are responsible for the activation of the DNA damage response (DDR), a complex network of proteins required for cell-cycle checkpoint maintenance and DNA repair. The G1/S checkpoint prevents cells from entering the S phase, whereas the G2/M checkpoint arrests cells with un-repaired DNA before entry into mitosis. We wanted to assess whether high YAP expression causes defects in cell cycle checkpoints, allowing cells to go through the cell cycle regardless of damage to their DNA. To examine the G1/S checkpoint, we exposed CGNPs to ionizing radiation (10 Gy), and determined the percentage of cells in the S phase 18 h post-treatment by quantifying bromo-deoxyuridine (BrdU) incorporation during a 1-h pulse. Upon IR treatment, both GFP-and YAP-expressing CGNPs showed a strong reduction of the number of cells incorporating BrdU; however, YAPexpressing cells have a significantly higher S-phase ratio (%BrdU-positive of treated/%BrdU-positive of untreated), suggesting a mild defect in the G1/S checkpoint ( Figure 2c ). The infection efficiency was similar in both GFP-and YAP-infected cultures (representative images; Supplementary Figure 2 ). To determine whether the G2/ M checkpoint was disabled in YAP-infected irradiated CGNPs, we evaluated P-Hist3 levels at an early time point (1 h) after radiation. GFP-transduced cells showed an 80% reduction of the number of P-Hist3-positive cells as compared to untreated cells. In contrast, YAPexpressing CGNPs showed only a 50% reduction of cells undergoing mitosis, indicating that the G2/M checkpoint was defective ( Figure 2c ).
YAP overexpression affects DNA repair and causes genomic instability
Defects in cell cycle checkpoints might result in genomic instability. We asked at which level YAP was affecting the DDR. Breaks in DNA are marked by the formation of protein complexes termed ionizing radiation-induced foci, which can be identified when analyzed by immunostaining for proteins comprising these complexes. To determine whether YAP-infected cells had reduced DNA damage, we carried out immunostaining for p53-binding protein 1 (p53BP1), an important mediator of the DDR often used as a marker of the To distinguish between these two possibilities, we carried out comet assays to detect broken DNA, in irradiated GFP-or YAP-infected CGNPs. In the comet . Table summarizes the number of breaks/cell after analysis of 50 irradiated GFP-or YAP-transduced CGNPs. YAP transduction was also associated with increased genomic instability in a mouse medulloblastoma cell line (Supplementary Figure 3B) . Statistically significant differences are indicated as **Po0.01; ***Po0.001.
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Nuclear DNA is unwound under alkaline conditions and fragments resulting from strand breaks can migrate away from the nuclei under an electric field, forming a 'comet tail' when stained. We quantified the amount of DNA damage by measuring tail lengths. As shown in Figure 3b , comet tails can be detected in GFP-infected CGNPs at 9 h post-irradiation, but to a lesser extent at 24 h post-irradiation, indicating that most of the damaged DNA is repaired at that point.
In contrast, at 9 h after irradiation, YAP-infected cells had strikingly pronounced comet tails. Comet tails persisted in YAP-infected CGNPs 24 h after irradiation, a time point at which we can detect proliferation in these cells ( Figure 2 ). To analyze whether the DNA repair defect leads to chromosomal alterations, we performed metaphase spreads on GFP-or YAP-infected CGNPs 24 h after irradiation. As shown in Figure 3c , YAP infection is associated with an increase in the number of cells with persistent DNA breaks. We also observed that YAP-transduced Pzp53 med cells (Berman et al., 2002) showed a similar loss of irradiation-induced foci and increased the number of cells with DNA breaks after irradiation (Supplementary Figure 3A and B) . These observations indicate that YAP expression enables cells to proliferate with un-repaired DNA, a condition that can lead to genomic instability, a hallmark of cancer cells. To address whether the effect of YAP was specific for radiation-induced DNA damage, we treated GFPand YAP-infected cells with the antibiotic bleomycin, which causes double-strand breaks in DNA. Similar to what we observed in irradiated cells, 9 and 24 h after treatment there were significantly fewer cells that contained foci among those overexpressing YAP, which indicates that the role of YAP promoting focus disassembly is not specific to radiation-induced damage in the DNA (Supplementary Figure 3C ).
YAP expression promotes inactivation of the checkpoint regulators ATM and Chk2
Entry into mitosis is marked by activation of the cyclindependent kinase (Cdk)1:cyclin B1 complex. During G2, Cdk1 is maintained in an inactive state by phosphorylation on Thr 14 and Tyr 15 (Castedo et al., 2002) ; dephosphorylation by cdc25 disinhibits Cdk1. To confirm that YAP-expressing cells continued to enter mitosis after irradiation, indicating inactivation of the G2/M checkpoint, we carried out western blotting for Tyr 15phosphorylated Cdk1. As shown in Figure 4a , irradiation results in increased Tyr15-phosphorylated Cdk1 in both GFP-and YAP-infected CGNPs. However, after 3 h, YAP-infected CGNPs show reduced levels of Tyr15phosphorylated Cdk1, indicating re-activation of Cdk1 at this early time point, when DNA breaks still persist. The reduction of inactive Cdk1 was associated with an increase in levels of cyclin B1, which is synthesized during interphase. Following metaphase, cyclin B1 is degraded; this degradation is required for completion of mitosis. Taken together, these results confirm that YAP-expressing irradiated CGNPs enter mitosis despite the presence of double-stranded DNA breaks, and they suggest that the G2/M arrest checkpoint is compromised by YAP expression.
These observations prompted us to examine whether YAP expression blocked activation of the G2/M checkpoint by affecting the activity of proteins involved in its regulation. Upon irradiation, the kinase ATM is activated by autophosphorylation and subsequently phosphorylates and activates Chk2 kinase. Chk2, in turn, phosphorylates cdc25c, resulting in its inactivation and preventing entry into mitosis (Reinhardt and Yaffe, 2009 ). Irradiation resulted in increased levels of phosphorylated ATM and its substrate Chk2 in both GFP-and YAP-infected cells. However, in the presence of ectopic YAP, ATM and Chk2 were more rapidly dephosphorylated (Figure 4b ; western blot with quantification below). We observed a similar trend towards Chk2 inactivation in MBCs obtained from SmoA1 medulloblastomas, cultured in vitro and transduced with either GFP or YAP. Our observation of ATM and Chk2 inactivation in YAP-infected CGNPs and MBC is consistent with relief from the G2/M checkpoint, and consequently, re-entry into mitosis despite the presence of un-repaired DNA breaks. We also observed reduced phosphorylation of histone H2AX in YAP-transduced irradiated CGNPs, further indicative of impaired DDR pathway signaling (Supplementary Figure 4A ). Interestingly, we did not observe differential effects of YAP expression on the regulation of Chk1 or p53 activity after exposure to radiation in CGNPs or MBCs, indicating that YAP's downstream effectors preferentially target the ATM/Chk2 DDR pathway (Figure 4b ).
IGF2 is a candidate YAP target mediating proliferation and survival after irradiation We next wished to gain insight as to the mechanism through which YAP protects tumor cells from radiationinduced apoptosis and allows them to continue cycling. YAP functions in a complex with TEAD to regulate gene expression and proliferation (Zhao et al., 2008) . To determine which genes may be induced or suppressed by YAP in irradiated CGNPs, we carried out microarray analysis of mRNA prepared from GFP-or YAPinfected control or irradiated CGNPs. Among the genes most highly expressed in YAP-infected CGNPs was IGF2, confirmed by quantitative reverse transcriptionpolymerase chain reaction (PCR) (Figure 5a ). IGF2 mRNA expression was increased in both cell populations after irradiation, but the levels of IGF2 in the YAP-infected CGNPs were significantly higher than that in the GFP-infected cell under either condition (non-irradiated or irradiated). When we analyzed IGF2 protein levels in GFP-or YAP-infected CGNPs, we found that YAP-infected CGNPs expressed and secreted significantly more IGF2 (Figures 5b and c) .
IGF signaling is required for survival of CGNPs in vivo and in vitro, and increased activity of the IGF pathway is found in human medulloblastomas (Hahn et et al., 2010) . Interestingly, when we queried a genetically characterized database of over 100 human medulloblastomas (Northcott et al., 2009b) , we found that IGF2 was most highly expressed in the subclass of medulloblastomas associated with the activation of the Shh pathway (T-test, P ¼ 3.553E-14) (Figure 5d ). This class of tumors also expresses high levels of N-myc, Gli1 and miR17/92 (Pomeroy et al., 2002; Kool et al., 2008; Northcott et al., 2009b) . The increased level of IGF2 protein in YAP promotes radioresistance in medulloblastoma A Fernandez-L et al kinase Akt, which plays multiple roles in survival and proliferation. We have previously shown that Akt cooperates with Shh signaling to promote proliferation through stabilization of N-myc (Kenney et al., 2004) . Akt activity has been linked to abrogation of the G2/M checkpoint after irradiation, through inactivation of ATM/Chk2 (Kandel et al., 2002; Hirose et al., 2005) . Consistent with increased IGF1 receptor activity in response to IGF2 secretion, YAP-Smo-driven medulloblastomas exhibit higher levels of activated Akt (S473phosphorylated), most notably in cells surrounding the vasculature (Figure 5g) ; interestingly, these cells also express the highest levels of YAP and they have been proposed to function as tumor-repopulating cells after irradiation (Hambardzumyan et al., 2008; Fernandez-L et al., 2009) . Taken together, these observations raise the possibility that YAP-mediated IGF2 induction not only promotes survival and proliferation through Akt activation, but may also affect the phosphorylation of ATM/Chk2, resulting in disruption of the G2/M checkpoint.
IGF2 is required for YAP-mediated G2/M arrest override and cell survival and proliferation after irradiation To address whether IGF2/Akt activity regulates the YAP-associated DDR defect after radiation, we used Shh-treated CGNP cultures. Confirming our observations ( Figure 5) , YAP infection is associated with increased Akt activity (Figure 6a ) as determined by phosphorylation of S473. Treatment of YAP-infected CGNPs with the drug LY294002, which inhibits phosphoinositide-3 kinase, the upstream activator of Akt, reduced levels of S473-phosphorylated Akt. After irradiation, we saw induction of ATM phosphorylation in GFP-and YAP-infected CGNPs, although to a lesser extent in the presence of ectopic YAP, indicating reduced activity of this kinase. In keeping with reduced ATM activity in the presence of YAP, we also observed reduced Chk2 phosphorylation. In the presence of LY294002, full ATM and Chk2 phosphorylation were recovered, indicating that YAP requires Akt activity for its suppressive effect on ATM and Chk2. We next wished to determine whether IGF2 is necessary for the effects of YAP on the DDR. To this end, we used retroviruses targeting IGF2 for short hairpin RNA (shRNA)-mediated knockdown. As shown in Figure 6b , YAP-infected CGNPs transduced with these retroviruses showed strikingly reduced levels of IGF2, in comparison with YAP-infected CGNPs transduced with retroviruses carrying a scrambled, nonspecific shRNA sequence. Consistent with IGF2 being an upstream activator of Akt, IGF2 knockdown was associated with reduced Akt Ser473 phosphorylation. In addition, knocking down IGF2 in YAP-expressing cells led to a recovery of phospho-ATM and phospho-Chk2 levels, as well as phospho-Cdk1, comparable to those observed in GFP-infected cells. The increase in inactive Cdk1 when IGF2 is knocked down indicates cells arresting after radiation, due to a restored G2/M checkpoint. IGF2 knockdown also blocked the effects of YAP on DNA damage-dependent focus formation after irradiation (Figure 6c) , causing a significant rescue of focus formation as determined by immunofluorescent staining for p53BP1. Moreover, IGF2 knockdown impaired the effects of YAP expression on CGNP survival after irradiation, as well as proliferation (Figure 6d ). These results are consistent with IGF2 and its downstream effector Akt being necessary for the ability of YAP to inactivate the G2/M checkpoint, permitting ongoing proliferation and enhancing survival of irradiated cells.
Discussion
Amplification of the YAP gene locus as well as YAP protein overexpression has been reported in a wide spectrum of human and murine tumors. We have previously shown that YAP is a downstream target of mitogenic Shh signaling that promotes proliferation and inhibits apoptosis of cerebellar granule cell precursors and we showed that YAP is overexpressed and amplified in the Shh-associated class of medulloblastomas (Fernandez-L et al., 2009) . Here, we report a new role for YAP in promoting IGF2/Akt-dependent radioresistance and ongoing proliferation in the presence of un-repaired DNA, illustrating a novel link between Shh signaling, YAP and the Akt pathway. We show that YAP activity markedly induces IGF2 transcription, in the absence and presence of radiation. IGF2, in turn, activates Akt downstream of phosphoinositide 3-kinase (PI3K), providing cells with a survival and proliferative advantage, and allowing them to inactivate cell cycle checkpoints (Figure 7) . Many studies have implicated PI3K and Akt in cell survival, through its effects on FKHR proteins and Bcl2 family members (Brunet et al., 2001; Burgering and Kops, 2002; Duronio, 2008) , and Akt is essential for CGNP survival (Dudek et al., 1997) . Transcriptional profiling of human medulloblastomas has shown increased expression of IGF2 (Pomeroy et al., 2002) , and our report clearly links high levels of IGF2 expression with the Shh-associated subclass of medulloblastomas. IGF2 has been shown to be indispensable for the formation and progression of Shh-driven murine medulloblastomas (Hahn et al., 2000; Corcoran et al., 2008) and to synergize with SHh in the induction of tumor formation (Rao et al., 2004) . IGF2 has previously been shown to promote proliferation of MBCs and cerebellar neural cell precursors through the activation of Akt (Hartmann et al., 2005) .
Our results show that ectopic YAP expression accelerates medulloblastoma onset and aggressiveness, and also confers a survival advantage after tumor radiation. This has particularly important implications for medulloblastomas; owing to their radiosensitivity, radiation therapy is a standard in children older than 3 years of age (Mueller and Chang, 2009 ). We show here that 3 h after radiation, YAP-driven SmoA1 medulloblastomas feature higher levels of proliferation markers and reduced apoptosis. In vitro, we found a similar effect when we irradiated GFPor YAP-overexpressing CGNPs. CGNPs expressing YAP not only proliferated more than GFP-expressing cells after radiation, but also failed to arrest in response to radiation, skipping the G2/M checkpoint. Defective G2/M checkpoint activation in the presence of DNA damage has been linked to Akt activity. Activation of Akt suppresses the checkpoint by inhibiting the DDR pathways, either ATM/Chk2 or ATR/ Chk1, depending on the cellular context (Kandel et al., 2002; Shtivelman et al., 2002; Hirose et al., 2005; Xu et al., 2010) . In agreement with these studies, we observed a decrease in phosphorylated ATM and Chk2 in irradiated YAP-overexpressing CGNPs and MBCs compared to GFP-expressing cells, and YAPtransduced cells showed fewer DNA damage-induced foci. The effects of YAP on ATM and Chk2 was reversed in the presence of a PI3K inhibitor, and when we knocked down IGF2, which also abolished the accelerating effect of YAP on DNA damage-dependent focus disassembly. Interestingly, a previous study has shown that aberrant activation of the Shh pathway through Ptc loss-of-function impairs the function of ATR/Chk1, a separate signaling cascade (Leonard et al., 2008) . We did not detect effects of YAP on this cascade (data not shown); however, the impact we report of YAP on ATM/Chk2 may synergize with an already defective DDR due to Smoothened-mediated Chk1 impairment.
The ability of cells to maintain genomic integrity is fundamental for protection from cancer development. Genomic instability characterizes almost all sporadic human cancers, although mechanisms causing it are still not well understood. High-throughput sequencing studies suggest that mutations in DNA repair genes do not account for the presence of genomic instability in many sporadic cancers (Negrini et al., 2010) . Alternatively, activation of oncogenes, and more generally of growth signaling pathways, has been shown to induce genomic instability in mammalian cells cultured in vitro and in mouse models (Hernando et al., 2004; Negrini et al., 2010) . Hyperactive Shh pathway activity has been shown to induce genomic instability and the development of spontaneous and ionizing radiation-induced tumors (Leonard et al., 2008) . Now we show that high levels of YAP expression further contribute to the generation of genomic instability as irradiated YAP-expressing cells present a higher number of chromosomal alterations. The role of genomic instability has remained a controversial issue in cancer biology. Although it is still unclear if it is necessary for tumorigenesis to occur, genomic instability certainly provides the tumor with an advantage in terms of faster progression through the many stages of tumorigenesis (Sieber et al., 2003) . Indeed, we show that ectopic expression of YAP accelerates medulloblastoma onset and produces tumors that are highly aggressive and rapidly lethal.
YAP expression is particularly high in the PVN of medulloblastomas, where the tumor-repopulating cells reside. We have previously shown that 48 h after radiation, the YAP-positive population starts to expand (Fernandez-L et al., 2009) . Hambardzumyan et al. (2008) elegantly demonstrated that the PI3K-Akt pathway regulates survival of these tumor-repopulating cells residing in the PVN. These results point to the importance of YAPregulating survival and proliferation post-radiation, allowing the cells to skip the cell cycle checkpoints and expand despite the un-repaired damage in their DNA, contributing ultimately to genomic instability. Further studies will address whether YAP-induced genomic instability is solely a consequence of the Akt-mediated cell cycle checkpoint suppression or whether Akt lying downstream of YAPinduced IGF2 could also inhibit the DNA repair machinery, as previous studies have suggested (Plo et al., 2008) (Figure 7) . Our results suggest that targeting Akt downstream of YAP would be useful for medulloblastoma therapy to reduce the dose of radiation needed and to prevent tumor recurrence, by radiosensitizing PVN-residing tumor-repopulating cells.
Materials and methods
Animal studies
Harvest of CGNPs from neonatal mice, preparation of cerebella and tumor tissue from wild-type and mutant mice for histological analysis and irradiation of tumor-bearing mice were carried out in compliance with the Memorial Sloan-Kettering Institutional animal care and use committee guidelines. NeuroD2-SmoA1 mice were provided by Jim Olson (Fred Hutchinson Cancer Research Center, Seattle, MA, USA). Ptc þ /À mice were provided by Kathryn Anderson (Memorial 
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Figure 7 YAP-mediated IGF2 expression drives cell survival, proliferation and genomic instability. Model suggesting the mechanism through which oncogenic YAP expression permits cell proliferation and survival after radiation-induced DNA damage. YAP induces IGF2 expression in CGNPs and medulloblastoma cells. IGF2 activates the PI3K/Akt pathway, promoting survival and increasing proliferation of these cells. In addition, increased activation of Akt leads to faster ATM and Chk2 dephosphorylation after radiation, subsequently deactivating the DDR and removing the G1/S and G2/M checkpoints. Favoring survival, proliferation and genomic instability confers an advantage to YAPexpressing tumor cells. Inhibiting IGF2/Akt signaling in tumors with high YAP expression may prevent recurrence and enable use of lower radiation doses by increasing tumor cell radiosensitivity.
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A Fernandez-L et al Sloan-Kettering Cancer Center, New York, NY, USA). Nonobese diabetic/severe combined immune deficiency mice were purchased from The Jackson Laboratory (Bar Harbor, ME, USA).
Human tumor collection and expression analysis
Exon array profiling and data analysis with tumor subgrouping were performed as published (Northcott et al., 2009a) .
CGNPs and MBC culture CGNP cultures were generated as described previously (Kenney and Rowitch, 2000) . Cells were plated on individual poly-DL-ornithine (Sigma-Aldrich, St Louis, MO, USA) precoated plates or pre-coated glass coverslips. In all cases, cells were treated with 3 mg/ml of Shh. Where indicated, LY294002 (Sigma-Aldrich) was used at a concentration of 10 nM for 6 h. MBCs were obtained from SmoA1 mouse medulloblastomas. Briefly, tumors were disassociated and cells were incubated in Trypsin/EDTA solution for 30 min, and then passed through a cell strainer. Cells were subsequently separated on a density step gradient of 35 and 60% Percoll solution (Sigma-Aldrich). Purified MBCs were enriched by preplating on uncoated tissue culture dishes to remove adherent fibroblasts and glial cells. Non-adherent cells were plated on tissue culture dishes pre-coated with poly-D-lysine (Sigma-Aldrich) and Matrigel (BD Biosciences, Franklin Lakes, NJ, USA), infected with retroviruses 24 h later, and cultured for 24 or more hours before implantation or irradiation.
Tumor cell implantation
In total, 0.2 million MBCs were injected in the cortices of P2 non-obese diabetic/severe combined immune deficiency or C57BL/6 pups with a stereotaxic syringe.
Retrovirus production and infection
The YAP cassette was cloned from pBabe-YAP1 (Addgene, Cambridge, MA, USA) into the retroviral vector pWzl. shRNA interference sequences targeting IGF2 at the 3 0 or 5 0 end of the coding sequence were designed using the Cold Spring Harbor Laboratory RNAi OligoRetriever database and ligated into pSHAG vector, and then transferred to MSCV retroviral vector and produced as described (Nahle et al., 2008) . A control scrambled shRNA retrovirus was also prepared. The 293 EBNA (Invitrogen, Carlsbad, CA, USA) packaging cells were co-transfected with gag-pol and VSVg packaging plasmids plus pWzl-eGFP, pWzl-YAP1, pMSCV-IGF2shRNA or a control scrambled shRNA using Fugene 6 transfection reagent (Roche Applied Science, Indianapolis, IN, USA). The media were changed 12 h after transfection and supernatants (8 ml) were harvested at 24 and 48 h and filtered through 0.45-mm syringe filters. For infection, Shh-treated CGNPs were exposed to the viral supernatants for 3 h. Viral supernatant was then removed and replaced with fresh medium þ Shh.
RNA extraction and real-time PCR
Total RNA from cerebellar granule neural precursors was extracted and purified using the MiRvana kit (Ambion, Austin, TX, USA). cDNA was prepared from 1 mg total RNA by using iScript cDNA Synthesis kit (Bio-Rad Laboratories, Hercules, CA, USA). Quantitative PCR was performed using TaqMan Universal PCR Master Mix (Applied Biosystems, Foster City, CA, USA). RNA expression data were acquired and analyzed using a StepOnePlus Real-Time PCR system (Applied Biosystems). Average results and standard errors are presented.
TaqMan probes used for quantitative PCR were IGF2 (Mm01163433-m1) and control HPRT1 (Mm01545399-m1).
Protein preparation and immunoblotting
Protein extracts were prepared as described previously (Kenney and Rowitch, 2000) . Protein content was determined by using the Bio-Rad protein assay. In all, 50-75 mg of each sample was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis on 8-10% polyacrylamide gels and then transferred in 20% methanol buffer at 4 1C to Immobilon polyvinylidene difluoride (Millipore, Billerica, MA, USA) membranes. Immunoblotting was carried out according to standard methods. Antibodies used for western blotting were: YAP1 (Abcam, Cambridge, MA, USA), phospho-Akt (Ser473), phospho-Cdk1 (Tyr15), phospho-Chk2 (Thr68), total Akt and cleaved caspase 3 (Cell Signaling, Danvers, MA, USA), phospho-ATM (Ser1981) (Rockland Immunochemicals, Inc., Gilbertsville, PA, USA), Chk2 (Millipore), IGF2 and b-tubulin (Sigma-Aldrich), vascular endothelial growth factor, and cyclins D2 and B1 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA). Donkey anti-mouse horseradish peroxidase-linked secondary was from Jackson Research Laboratories and goat anti-rabbit from Thermo Scientific. Peroxidase activity was detected using Amershams's ECL reagents and exposing membranes to Kodak Biomax film.
Cell and tissue immunostaining For immunofluorescence, 8 mm sections of paraformaldehydefixed/paraffin-embedded tissues were first de-waxed and rehydrated before antigen retrieval. CGNPs were cultured on poly-DL-ornithine-coated glass coverslips as described previously. Cells were fixed with 4% paraformaldehyde for 20 min. Immunofluorescent staining of sections and cells was carried out according to standard methods. Immunohistochemical staining was performed using a Discovery XT automated staining processor (Ventana Medical Systems, Inc., Tucson, AZ, USA). Antibodies used were as follows: Ki67 (Vector Labs, Burlingame, CA, USA), YAP1 (Abcam), CD31 (BD Transduction Laboratories, Mississauga, ON, Canada), GFP (Invitrogen), BrdU (BD Biosciences), p53BP1 and IGF2 (Novus Biologicals, Littleton, CO, USA), phospho-histone 3, cleaved caspase 3 and phospho-Akt (Ser473) (Cell Signaling).
Image capturing
Staining of cultured primary cells and tissue sections was visualized with a Leica DM5000B microscope and images were taken using the Leica FW400 software. For quantification, TIFF images of 5-10 random fields were taken for each experimental group and average pixel intensities were measured using the ImageJ and Volocity softwares.
Mitosis spreads
Metaphase preparations were carried out by the Molecular Cytogenetics core facility at Memorial Sloan-Kettering Cancer Center according to standard procedures.
Comet assay
The Comet assay was performed with the Trevigen kit and following the manufacturer's instructions. Tail lengths were calculated using the Comet Assay IV software. Averages from four independent experiments were calculated and representative pictures are shown.
Enzyme-linked immunosorbent assay
Supernatants from CGNPs infected with GFP or YAP and subsequently cultured in 800 ml minimal media without N2 supplement were collected. IGF2 enzyme-linked immunosorbent assay was performed using the R&D systems kit and following the manufacturer's instructions. Triplicates were used in each case and the average from three independent experiments is shown.
